Novo Nordisk A/S (NYSE:NVO)
$ 135.57 1.54 (1.15%) Market Cap: 603.92 Bil Enterprise Value: 606.48 Bil PE Ratio: 47.09 PB Ratio: 42.29 GF Score: 92/100

Novo Nordisk A/S to Discuss International Operations Call Transcript

May 21, 2021 / 11:30AM GMT
Release Date Price: $40.65 (+0.58%)
Operator

Hello, and welcome to the Novo Nordisk A/S International operations conference call. (Operator Instructions) Today, I'm please to present Karsten Knudsen, CFO. Please go ahead with your meeting.

Karsten Munk Knudsen;S;Executive VP
Novo Nordisk A;CFO & Member of the Management Board

/- -

Thank you, and welcome to the Novo Nordisk Topical Investor Conference Call. Today, our focus will be on International Operations and the related commercial strategies and performance of our commercial unit there. As always, we may cover forward-looking statements on today's presentations and Q&A sessions. Such statements are inherently uncertain. And as a consequence, actual results may differ from what we predict.

Today's session is structured in a way where following a brief presentation by myself, I'm joined by my 2 colleagues, Mike Doustdar, EVP and Head of International Operations, and Senior Vice President of Northwest Europe, Frederik Kier.

We'll go through each of the regions in International Operations

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot